Author/Authors :
Samarasinghe، Rasika M Rasika M نويسنده Nanomedicine-Laboratory of Immunology and Molecular Biomedical Research (NLIMBR), School of Medicine, Faculty of Health, Deakin University, Geelong, Samarasinghe, Rasika M Rasika M , Kanwar، Rupinder K Rupinder K نويسنده Nanomedicine-Laboratory of Immunology and Molecular Biomedical Research (NLIMBR), School of Medicine, Faculty of Health, Deakin University, Geelong, Kanwar, Rupinder K Rupinder K , Kanwar، Jagat R Jagat R نويسنده Nanomedicine-Laboratory of Immunology and Molecular Biomedical Research (NLIMBR), School of Medicine, Faculty of Health, Deakin University, Geelong, Kanwar, Jagat R Jagat R
Abstract :
Cell based therapeutics is one of the most rapidly advancing medical fields, bringing together a range of fields
including transplantation, tissue engineering and regeneration, biomaterials and stem cell biology. However,
traditional cell-based therapeutics have many limitations, one of which is their harmful effects exhibited on
healthy body cells due to their lack of specificity. Nanomedicine is providing an alternative treatment strategy
that is more targeted and specific to a range of diseases. Varying from polymers conjugated with drugs or tissue
targeting molecules, to proteins encapsulated within a polymer shell, nanomedicine will without a doubt play a
major role in designing effective cell-based therapeutics that can overcome certain classical problems. These
may include from addressing the problem of non-specificity of contemporary treatments to overcoming
mechanical barriers, such as crossing cell membranes. This review summarises the recent work on nano-based
cell therapy as a regenerative agent and as a therapeutic for cancer and neurological diseases.
